StockData
Oragenics Inc logo

Oragenics Inc (OGEN) income statement

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.19−0.02 (-10.00%)

Close on Nov 18, 2026Market cap $852.76KP/E –Yield –

See a number that looks wrong?